Sitka Biopharma Overview
- Founded
- 2013

- Status
- Private
- Employees
- 5

- Latest Deal Type
- Later Stage VC
- Latest Deal Amount
- $3.1M

- Investors
- 3
Sitka Biopharma General Information
Description
Developer of a nano-particle polymer platform technology designed to improve drug absorption for cancer treatments. The company's platform increases absorption of drugs in difficult-to-penetrate tissues, and addresses the absorption challenges of intravesical chemotherapy for bladder cancer, and later intraperitoneal delivery for ovarian cancer, enabling caregivers to transform chemotherapies to benefit patients by enhancing drug efficacy and improving tolerability.
Contact Information
- 2405 Wesbrook Mall
- Fourth Floor
- Vancouver, British Columbia V6T 1Z3
- Canada
Sitka Biopharma Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Later Stage VC | 11-Feb-2019 | $3.1M | 00.00 | Completed | Pre-Clinical Trials | |
2. Seed Round | 07-Aug-2016 | 00.00 | 00.00 | Completed | Pre-Clinical Trials | |
1. Spin-Off | 03-Dec-2013 | Completed | Pre-Clinical Trials |
Sitka Biopharma Comparisons
Industry
000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialSitka Biopharma Competitors (34)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Horama | Venture Capital-Backed | Paris, France | 00 | 000.00 | 00000000000 | 000.00 |
000000000000 00000 | Venture Capital-Backed | Tokyo, Japan | 0 | 000.00 | 0000000000 0 | 000.00 |
0000000 | Venture Capital-Backed | Indianapolis, IN | 0 | 000.00 | 00000000000 | 000.00 |
000 00000000000000 | Venture Capital-Backed | Debrecen, Hungary | 00 | 00.000 | 0000000000 | 00.000 |
000000000000 | Venture Capital-Backed | Seattle, WA | 00 | 000.00 | 00000000000 | 000.00 |
Sitka Biopharma Executive Team (4)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Michael Parr Ph.D | Co-Founder, President, Chief Scientific Officer & Board Member | ||
Robert Geckeler | Chief Development Officer |
Sitka Biopharma Board Members (3)
Name | Representing | Role | Since |
---|---|---|---|
Jack Geltosky Ph.D | Self | Board Member | 000 0000 |
Kristine Swiderek Ph.D | Self | Board Member | 000 0000 |
Michael Parr Ph.D | Sitka Biopharma | Co-Founder, President, Chief Scientific Officer & Board Member | 000 0000 |
Sitka Biopharma Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialSitka Biopharma Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
GF Securities | Investment Bank | Minority | 000 0000 | 000000 0 | |
Quark Venture | Venture Capital | Minority | 000 0000 | 000000 0 | |
CDRD Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |